Cresset Asset Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,460
Closed -$219K 1877
2024
Q4
$219K Sell
11,460
-20,567
-64% -$435K ﹤0.01% 1520
2024
Q3
$871K Buy
32,027
+9,969
+45% +$255K ﹤0.01% 1228
2024
Q2
$553K Buy
22,058
+3,749
+20% +$108K ﹤0.01% 1390
2024
Q1
$610K Buy
18,309
+2,178
+14% +$74.4K ﹤0.01% 1236
2023
Q4
$576K Sell
16,131
-1,108
-6% -$35.2K ﹤0.01% 1159
2023
Q3
$591K Sell
17,239
-1,388
-7% -$52.8K ﹤0.01% 1096
2023
Q2
$748K Buy
+18,627
New +$741K ﹤0.01% 1074
2019
Q2
Sell
-862
Closed -$43K 1744
2019
Q1
$43K Buy
862
+272
+46% +$12K ﹤0.01% 828
2018
Q4
$22K Buy
+590
New +$21.5K ﹤0.01% 696

Other funds holding XRAY

Cresset Asset Management's XRAY Position: Q1 2025 in Review

Cresset Asset Management sold out of Dentsply Sirona (XRAY) in Q1 2025, closing a stake of 11,460 shares — an estimated $219K sold.

Cresset Asset Management first reported a position in XRAY in Q4 2018 and held it in 9 quarters. The position peaked at $871K in Q3 2024. 359 funds tracked by Wall St. Rank hold XRAY as of Q1 2025.

  • Cresset Asset Management reported no remaining Dentsply Sirona position as of Q1 2025 after selling out during the quarter.
  • Cresset Asset Management sold 11,460 Dentsply Sirona shares in Q1 2025, an estimated $219K.
  • Cresset Asset Management first reported a position in Dentsply Sirona in Q4 2018 and held it in 9 quarters.
  • Cresset Asset Management's Dentsply Sirona position peaked at $871K in Q3 2024.
  • 359 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2025.

Based on Cresset Asset Management's 13F filing for Q1 2025, filed 13 May 2025.